Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-25
DOI
10.1038/s41598-017-01425-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives
- (2016) Igor A. Schepetkin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A Macroscopic Mathematical Model for Cell Migration Assays Using a Real-Time Cell Analysis
- (2016) Ezio Di Costanzo et al. PLoS One
- The Role of Formylated Peptides and Formyl Peptide Receptor 1 in Governing Neutrophil Function during Acute Inflammation
- (2015) David A. Dorward et al. AMERICAN JOURNAL OF PATHOLOGY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Conformational Ensembles Explored Dynamically from Disordered Peptides Targeting Chemokine Receptor CXCR4
- (2015) Marian Vincenzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T cell migration in rheumatoid arthritis
- (2015) Mario Mellado Frontiers in Immunology
- Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells
- (2015) Liang Zhang et al. OncoImmunology
- Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
- (2015) Ali Munaim Yousif et al. PLoS One
- Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
- (2015) Katia Bifulco et al. Oncotarget
- Retro-inversal of Intracellular Selected β-Amyloid-Interacting Peptides: Implications for a Novel Alzheimer’s Disease Treatment
- (2014) Nicola Acerra et al. BIOCHEMISTRY
- N-terminal region of human chemokine receptor CXCR3: Structural analysis of CXCR3(1–48) by experimental and computational studies
- (2014) R. Raucci et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- UPARANT: A Urokinase Receptor-Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency
- (2014) M. V. Carriero et al. MOLECULAR CANCER THERAPEUTICS
- A Urokinase Receptor-Derived Peptide Inhibiting VEGF-Dependent Directional Migration and Vascular Sprouting
- (2013) K. Bifulco et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
- (2013) Vadivel Parthsarathy et al. PLoS One
- The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target
- (2013) Thomas V. O'Halloran et al. Theranostics
- Differential Expression of the G-Protein–Coupled Formyl Peptide Receptor in Melanoma Associates With Aggressive Phenotype
- (2012) Nitin Chakravarti et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Potent Retro-Inverso d-Peptide for Simultaneous Targeting of Angiogenic Blood Vasculature and Tumor Cells
- (2012) Ying Li et al. BIOCONJUGATE CHEMISTRY
- Why does cancer therapy lack effective anti-metastasis drugs?
- (2012) Georg F. Weber CANCER LETTERS
- G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma
- (2012) Mingyong Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Crystal Structure of the Urokinase Receptor in a Ligand-Free Form
- (2012) Xiang Xu et al. JOURNAL OF MOLECULAR BIOLOGY
- Perspective: The right trials
- (2012) Patricia S. Steeg NATURE
- Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion
- (2012) Katia Bifulco et al. PLoS One
- uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
- (2011) Ida K. Lund et al. CURRENT DRUG TARGETS
- The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
- (2011) Maria Vincenza Carriero et al. CURRENT PHARMACEUTICAL DESIGN
- Conformational Regulation of Urokinase Receptor Function
- (2011) Henrik Gårdsvoll et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of β-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer’s Disease
- (2010) Mark Taylor et al. BIOCHEMISTRY
- Osteopontin is a marker for cancer aggressiveness and patient survival
- (2010) G F Weber et al. BRITISH JOURNAL OF CANCER
- Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention
- (2010) Jody M Mason Future Medicinal Chemistry
- Unnatural Amino Acid Side Chains as S1, S1′, and S2′ Probes Yield Cationic Antimicrobial Peptides with Stability toward Chymotryptic Degradation
- (2010) Rasmus Karstad et al. JOURNAL OF MEDICINAL CHEMISTRY
- The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence
- (2010) K. BIFULCO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease
- (2010) Balpreet Matharu et al. PEPTIDES
- The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
- (2009) Francesco Blasi et al. FEBS LETTERS
- Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis
- (2009) M. V. Carriero et al. MOLECULAR CANCER THERAPEUTICS
- Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way
- (2009) Peter Carmeliet et al. Nature Reviews Clinical Oncology
- Regulation of cell signalling by uPAR
- (2009) Harvey W. Smith et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
- Antimicrobial Peptides with Stability toward Tryptic Degradation†
- (2008) Johan Svenson et al. BIOCHEMISTRY
- Molecular mechanisms of metastasis
- (2008) Georg F. Weber CANCER LETTERS
- Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy
- (2008) A. P. Mazar CLINICAL CANCER RESEARCH
- An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor
- (2008) Katia Bifulco et al. FEBS LETTERS
- Structure and ligand interactions of the urokinase receptor (uPAR)
- (2008) Magnus Kjaergaard Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now